Can I give Arcoxia (etoricoxib) for headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Arcoxia (Etoricoxib) Be Used for Headache?

Arcoxia (etoricoxib) is not a recommended first-line treatment for most headaches, but it may be considered as an NSAID option for migraine headaches when other NSAIDs are appropriate, though it is not specifically mentioned in major migraine treatment guidelines.

Evidence-Based Recommendations for Headache Treatment

For Migraine Headaches

The most recent 2025 American College of Physicians guidelines provide a clear treatment algorithm 1:

First-line approach:

  • Start with standard NSAIDs (aspirin, ibuprofen, naproxen, diclofenac, or celecoxib), acetaminophen, or their combination
  • Ensure adequate dosing before escalating therapy

Second-line approach:

  • If NSAIDs alone fail, add a triptan to the NSAID or acetaminophen
  • This combination therapy should be started as early as possible after headache onset 1

Specific NSAIDs mentioned in guidelines include: aspirin, celecoxib, diclofenac, ibuprofen, and naproxen 1. Notably, etoricoxib (Arcoxia) is not specifically listed in these major migraine treatment guidelines.

For Tension-Type Headache

The 2024 VA/DoD guidelines recommend 2:

  • Acute treatment: Ibuprofen 400 mg or acetaminophen 1000 mg
  • Prevention of chronic TTH: Amitriptyline

Again, etoricoxib is not mentioned as a recommended option.

Important Considerations About Etoricoxib

Cardiovascular Risk Profile

Etoricoxib carries significant cardiovascular concerns. The 2007 American Heart Association scientific statement on NSAIDs explicitly cautions against etoricoxib 3:

  • Etoricoxib lies on the highly COX-2-selective end of the spectrum, similar to diclofenac
  • It has been associated with increased risk of thrombotic events
  • It should not be among first choices for pain relief, especially in individuals with or at risk for cardiovascular disease 3

Limited Evidence for Headache

While some research exists showing etoricoxib effectiveness for specific headache types:

  • Effective for preventing fasting-related headaches (Yom Kippur, Ramadan) 4, 5
  • May help certain indomethacin-responsive headache disorders 6
  • One case report for secondary cough headache 7

However, these are specialized scenarios, not general headache treatment.

Clinical Algorithm for Headache Treatment

Step 1: Identify Headache Type

  • Migraine: Moderate-severe unilateral throbbing with nausea/photophobia/phonophobia
  • Tension-type: Bilateral pressing/tightening, mild-moderate intensity

Step 2: For Migraine

  1. Mild episodic migraine: Standard NSAID (ibuprofen 400-800 mg, naproxen 275-550 mg) or acetaminophen, or combination 1
  2. Moderate-severe or failed NSAID: Add triptan to NSAID/acetaminophen 1
  3. Failed combination therapy: Consider CGRP antagonists (gepants) or other alternatives 1
  4. Never use: Opioids or butalbital 1

Step 3: For Tension-Type Headache

  • Ibuprofen 400 mg or acetaminophen 1000 mg 2

Critical Pitfalls to Avoid

Medication overuse headache: Limit acute treatment to ≤2 days per week for NSAIDs (≤15 days/month) 1. If using more frequently, preventive therapy is needed.

Cardiovascular risk: If etoricoxib is considered, screen carefully for cardiovascular disease or risk factors. The stepped-care approach prioritizes agents with lowest cardiovascular risk 3.

Cost considerations: Prescribe less costly recommended medications when equally effective 1.

Bottom Line

Use standard NSAIDs (ibuprofen, naproxen, aspirin) or acetaminophen as first-line for headache treatment. Etoricoxib is not guideline-recommended for routine headache management and carries cardiovascular concerns that make it a poor choice compared to safer, evidence-based alternatives. If a COX-2 selective agent is specifically needed due to gastrointestinal intolerance, celecoxib is mentioned in guidelines and would be preferable to etoricoxib 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.